ANI Pharmaceuticals reported $143.47M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
ANI Pharmaceuticals USD 143.47M 401K Mar/2026
Aurora Cannabis CAD 175.08M 55.48M Mar/2026
Canopy Growth CAD 110.51M 4.96M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Hikma Pharmaceutical USD 1.08B 96M Jun/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.29B 135M Mar/2026
Omeros USD 712K 266K Sep/2021
Perrigo USD 1.12B 27.6M Mar/2026
Sun Pharmaceuticals INR 102.43B 3.08B Mar/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025